AltrixBio Raises $5 Million Series A Financing and Appoints David Pass as CEO to Advance Lead Candidate into the Clinic
– Current CEO and Co-founder Nancy Briefs Transitions to Executive Chair of the Board – – Financing and Leadership Transition Strengthen Momentum Toward First Clinical Trial of AJN 003 for Type 2 Diabetes – LOWELL,…